These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2381961)

  • 1. [Biopharmaceutic studies of a bioerodible nystatin unit].
    Krusteva S; Lambov N; Velinov G
    Pharmazie; 1990 Mar; 45(3):195-7. PubMed ID: 2381961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination.
    de Aguiar MM; de Albuquerque RP; Marinho DS; Braga BR; Dornelas CB; Oliveira A; de Sousa VP; Torres SR; Alviano DS; Alviano CS; Cabral LM; Holandino C
    Drug Dev Ind Pharm; 2010 May; 36(5):594-600. PubMed ID: 19954405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release using a new bioerodible polyphosphazene matrix system.
    Laurencin CT; Koh HJ; Neenan TX; Allcock HR; Langer R
    J Biomed Mater Res; 1987 Oct; 21(10):1231-46. PubMed ID: 3693386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioerodible polymers for ocular drug delivery.
    Deshpande AA; Heller J; Gurny R
    Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release from bioerodible polymers: effect of drug type and polymer composition.
    Frank A; Rath SK; Venkatraman SS
    J Control Release; 2005 Feb; 102(2):333-44. PubMed ID: 15653155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS; Quadir MA; Haider SS
    J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system.
    Llabot JM; Manzo RH; Allemandi DA
    Int J Pharm; 2004 May; 276(1-2):59-66. PubMed ID: 15113614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal candidiasis: modern therapeutic tactics].
    Zlatkina AR
    Eksp Klin Gastroenterol; 2005; (6):15-8, 111. PubMed ID: 17378380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biopharmaceutic properties of slow-release codeine phosphate. Drug release from ion exchangers in vitro and in vivo].
    Wildfeuer A; Pfaff G; Lach P
    Arzneimittelforschung; 1994 Jun; 44(6):758-61. PubMed ID: 8053976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biopharmaceutic aspects of prolonged-release formulations with a methylxanthine base. I].
    Ventouras K; Gueurten D; Jaminet F
    Pharm Acta Helv; 1989; 64(1):19-23. PubMed ID: 2717645
    [No Abstract]   [Full Text] [Related]  

  • 13. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility.
    Efentakis M; Pagoni I; Vlachou M; Avgoustakis K
    Int J Pharm; 2007 Jul; 339(1-2):66-75. PubMed ID: 17408891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin.
    Moreno D; Zalba S; Colom H; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Sci; 2009 Jun; 37(3-4):341-50. PubMed ID: 19491025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
    Chen S; Zhu J; Cheng J
    Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPLC method for the determination of nystatin in saliva for application in clinical studies.
    Llabot JM; Allemandi DA; Manzo RH; Longhi MR
    J Pharm Biomed Anal; 2007 Nov; 45(3):526-30. PubMed ID: 17658236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile drug-delivery systems.
    Bussemer T; Otto I; Bodmeier R
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):433-58. PubMed ID: 11763497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
    Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
    J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.